Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitors
M R Mirza, R L Coleman, A González-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2021
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159]
M R Mirza, R L Coleman, A González-Martín, et al.
Gynecologic Oncology Reports
|
February 4, 2021
PARPi after PARPi in epithelial ovarian cancer
K G Essel, K Behbakht, T Lai, et al.
Gynecologic Oncology Reports
|
November 14, 2019
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
J Gillen, K A Mills, J Dvorak, et al.
Gynecologic Oncology
|
May 2, 2013
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer
K M Moxley, D M Benbrook, L Queimado, et al.
Gynecologic Oncology
|
April 6, 2020
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma
L R Duska, G R Petroni, N Varhegyi, et al.
Gynecologic Oncology
|
December 14, 2011
Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?
E K Nugent, E A Bishop, C A Mathews, et al.
Gynecologic Oncology
|
May 17, 2011
Malignant melanoma of the vulva: an extension of cutaneous melanoma?
K M Moxley, A N Fader, P G Rose, et al.
Gynecologic Oncology
|
December 7, 2024
Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices
T Castellano, O D Lara, C McCormick, et al.
Contemporary Clinical Trials
|
February 23, 2025
Design of a randomized controlled trial to test the efficacy of interrupting sitting on type 2 diabetes risk factors in children with overweight/obesity: The sedentary behavior study 3 protocol
B R Belcher, K L McAlister, J Zink, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitors
M R Mirza, R L Coleman, A González-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2021
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159]
M R Mirza, R L Coleman, A González-Martín, et al.
Gynecologic Oncology Reports
|
February 4, 2021
PARPi after PARPi in epithelial ovarian cancer
K G Essel, K Behbakht, T Lai, et al.
Gynecologic Oncology Reports
|
November 14, 2019
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
J Gillen, K A Mills, J Dvorak, et al.
Gynecologic Oncology
|
May 2, 2013
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer
K M Moxley, D M Benbrook, L Queimado, et al.
Gynecologic Oncology
|
April 6, 2020
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma
L R Duska, G R Petroni, N Varhegyi, et al.
Gynecologic Oncology
|
December 14, 2011
Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?
E K Nugent, E A Bishop, C A Mathews, et al.
Gynecologic Oncology
|
May 17, 2011
Malignant melanoma of the vulva: an extension of cutaneous melanoma?
K M Moxley, A N Fader, P G Rose, et al.
Gynecologic Oncology
|
December 7, 2024
Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices
T Castellano, O D Lara, C McCormick, et al.
Contemporary Clinical Trials
|
February 23, 2025
Design of a randomized controlled trial to test the efficacy of interrupting sitting on type 2 diabetes risk factors in children with overweight/obesity: The sedentary behavior study 3 protocol
B R Belcher, K L McAlister, J Zink, et al.
Page
of 7